FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma

Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma

Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies

Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma

Global cancer burden, prevention, and inequalities across regions

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC

Innovating cancer care access for low and middle-income countries

Reducing disparities through primary care: improving early detection and screening

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations

Resource disparities in cancer treatment in Mexico

Tepotinib in second line NSCLC treatment